ロード中...
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
BACKGROUND: Cardiovascular disease (CVD) is the main cause of death among hemodialysis (HD) patients. The effects of the dipeptidyl peptidase-4 inhibitor teneligliptin on CVD-related biomarkers in patients with type 2 diabetes mellitus (T2DM) receiving HD treatment are poorly understood. To determin...
保存先:
| 出版年: | Int J Gen Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835142/ https://ncbi.nlm.nih.gov/pubmed/27110135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S102070 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|